Electroanalitical system
US-2015369775-A1 · Dec 24, 2015 · US
US9322800B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9322800-B2 |
| Application number | US-201213261834-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 31, 2012 |
| Priority date | Sep 2, 2011 |
| Publication date | Apr 26, 2016 |
| Grant date | Apr 26, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Two techniques of determining hematocrit using impedance and phase angle to determine hematocrit are shown and described for correcting an analyte concentration.
Opening claim text (preview).
What is claimed is: 1. A method to determine analyte concentration in a blood sample, the method comprising: depositing a blood sample in a test chamber of a test strip having at least first and second electrodes in contact with a reagent and third and fourth electrodes not in contact with the reagent; driving a non-oscillating signal to the at least first and second electrodes to cause a reaction with the glucose in the blood sample and the reagent; measuring a current output of the reaction to establish a preliminary analyte concentration; applying a first oscillating input signal at a first frequency to third and fourth electrodes, the first frequency comprising any frequency in a range of about 20,000 Hertz to about 60,000 Hertz; determining a first estimated hematocrit based on an impedance from output signals of the third and fourth electrodes; applying a second oscillating input signal at a second frequency higher than the first frequency to the third and fourth electrodes, the second frequency comprising any frequency in a range from about 100,000 Hertz to about 1,000,000 Hertz; ascertaining a second estimated hematocrit based on a phase angle of output signals from the third and fourth electrodes; estimating a hematocrit of the blood sample based on the first and second estimated hematocrits; and deriving a final analyte concentration based on the preliminary analyte concentration and the hematocrit from the estimating step. 2. The method of claim 1 , in which the second frequency is one order of magnitude higher than the first frequency. 3. The method of claim 2 , in which the first frequency comprises about 25,000 Hertz and the second frequency comprises about 250,000 Hertz. 4. The method of claim 1 , in which the determining comprises utilizing an equation to determine the first estimated hematocrit HCT est1 : HCT est 1 = Z - c 1 m 1 where |Z| comprises the measured modulus of impedance of the blood sample at the first frequency, c1 and m1 are calibration coefficients. 5. The method of claim 4 , in which the measuring of a current output for the preliminary analyte concentration is performed prior to the estimating of the hematocrit. 6. The method of claim 4 , in which the deriving comprises calculating the final analyte concentration G F from: G F = ( I E 1 - k ( HCT final_est - h 0 ) - c 4 m 4 . Where I E comprises a magnitude of the measured end current HCT final _ est comprises the hematocrit, h 0 comprises nominal hematocrit, and k, m4 and c 4 comprise parameters from regressions data. 7. The method of claim 1 , in which the ascertaining comprises utilizing an equation to determine the second estimated hematocrit HCT est2 of the form: HCT est 2 = ( Φ - c 2 ) m 2 where Φ comprises a measured phase angle of the blood sample at one or more second frequencies higher than the first frequency; c2 and m2 comprise respective calibration coefficients. 8. The method of claim 1 , in which the ascertaining comprises utilizing an equation to determine the second estimated hematocrit HCT est2 of the form: HCT est 2 = ( Φ f 2 - Φ f 1 - c 3 ) m 3
Systems (G01N27/27 takes precedence) · CPC title
Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.